07/16/2025
1:08 PM | Rani Therapeutics (Filer)
| Form 424B5 | |
07/16/2025
1:14 PM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2025
11:15 PM | Rani Therapeutics (Filer)
| Form EFFECT | |
07/11/2025
3:30 PM | Rani Therapeutics (Filer)
| Form 424B5 | |
07/03/2025
1:49 PM | Rani Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/26/2025
3:06 PM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
4:45 PM | Farquharson Andrew (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
4:50 PM | Ausiello Dennis A (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
4:52 PM | BUTEL JEAN LUC (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
4:55 PM | Rani Therapeutics (Issuer)
Rometty Lisa Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
4:57 PM | IMRAN MIR A (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RANI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/30/2025
4:59 PM | Nanavaty Maulik (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
5:48 PM | Hashim Mir (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
5:20 PM | McKinley Kate (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:58 PM | Rani Therapeutics (Issuer)
Sanford Svai S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:58 PM | Imran Talat (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
7:59 AM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
8:58 PM | Rani Therapeutics (Filer)
| Form 424B5 | |
04/30/2025
7:00 AM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
7:10 AM | Rani Therapeutics (Filer)
| Form DEFA14A | |
04/16/2025
7:02 AM | Rani Therapeutics (Filer)
| Form DEF 14A | |
04/16/2025
7:03 AM | Rani Therapeutics (Filer)
| Form DEFA14A | |
04/16/2025
7:04 AM | Rani Therapeutics (Filer)
| Form ARS | |
04/09/2025
3:21 PM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
5:00 PM | McKinley Kate (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
12:12 PM | Imran Talat (Reporting)
Rani Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
7:20 AM | Rani Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
7:10 AM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:30 PM | Rani Therapeutics (Issuer)
South Cone Investments Limited Partnership (Reporting)
South Lake One LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
3:32 PM | Rani Therapeutics (Subject)
South Lake One LLC (Filed by)
| Form SC 13D/A | |
10/16/2024
5:04 AM | Rani Therapeutics (Filer)
| Form 424B5 | |
10/16/2024
5:06 AM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:10 PM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
5:05 AM | Rani Therapeutics (Filer)
| Form 424B5 | |
07/23/2024
5:06 AM | Rani Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
